Demographic and clinical characteristics of lymphedema patients in Léogâne, Haiti.

a The study period of the lymphedema management effectiveness cohort = 1995–1998. This number represents the mean yearly rate of ADL episodes reported in the year prior to their enrollment. N = 38 (missing information on 3 patients)b The study period of the lymphedema management effectiveness cohort = 1995–1998. This number represents the number of ADL episodes from patient enrollment in the cohort up until the observed ADL episode during which serum was collected.c Serum samples were collected from 52 ADL episodes among the 41 lymphedema patientsCFA: circulating filarial antigenN = 41 patients with 52 ADL episodes.